BR9811245A - Material polimérico farmaceuticamente aceitável, processo para a preparação de um material polimérico farmaceuticamente aceitável, uso de um polìmero aniÈnico ou tripolifosfato e de um polìmero catiÈnico, embalagem farmacêutica, e, formulação não aquosa para formar um material polimérico farmaceuticamente aceitável, in situ, em uma superfìcie do corpo - Google Patents

Material polimérico farmaceuticamente aceitável, processo para a preparação de um material polimérico farmaceuticamente aceitável, uso de um polìmero aniÈnico ou tripolifosfato e de um polìmero catiÈnico, embalagem farmacêutica, e, formulação não aquosa para formar um material polimérico farmaceuticamente aceitável, in situ, em uma superfìcie do corpo

Info

Publication number
BR9811245A
BR9811245A BR9811245-7A BR9811245A BR9811245A BR 9811245 A BR9811245 A BR 9811245A BR 9811245 A BR9811245 A BR 9811245A BR 9811245 A BR9811245 A BR 9811245A
Authority
BR
Brazil
Prior art keywords
polymeric material
pharmaceutically acceptable
acceptable polymeric
polymer
anionic
Prior art date
Application number
BR9811245-7A
Other languages
English (en)
Inventor
Peter William Dettmar
Ian Gordon Jollife
Oyvind Skaugrud
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717626.7A external-priority patent/GB9717626D0/en
Priority claimed from GBGB9717627.5A external-priority patent/GB9717627D0/en
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BR9811245A publication Critical patent/BR9811245A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D105/00—Coating compositions based on polysaccharides or on their derivatives, not provided for in groups C09D101/00 or C09D103/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

"MATERIAL POLIMéRICO FARMACEUTICAMENTE ACEITáVEL, PROCESSO PARA A PREPARAçãO DE UM MATERIAL POLIMéRICO FARMACEUTICAMENTE ACEITáVEL, USO DE UM POLìMERO ANIÈNICO OU TRIPOLIFOSFATO E DE UM POLìMERO CATIÈNICO, EMBALAGEM FARMACêUTICA, E, FORMULAçãO NãO AQUOSA PARA FORMAR UM MATERIAL POLIMéRICO FARMACEUTICAMENTE ACEITáVEL, IN SITU, EM UMA SUPERFìCIE DO CORPO" A invenção fornece um material polimérico farmaceuticamente aceitável formado in situ em uma superfície de corpo e um processo para a preparação de material. O material polimérico é formado aplicando-se um polímero aniónico e um polímero catiónico na superfície na presença de água.
BR9811245-7A 1997-08-21 1998-08-10 Material polimérico farmaceuticamente aceitável, processo para a preparação de um material polimérico farmaceuticamente aceitável, uso de um polìmero aniÈnico ou tripolifosfato e de um polìmero catiÈnico, embalagem farmacêutica, e, formulação não aquosa para formar um material polimérico farmaceuticamente aceitável, in situ, em uma superfìcie do corpo BR9811245A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9717626.7A GB9717626D0 (en) 1997-08-21 1997-08-21 Organic compositions
GBGB9717627.5A GB9717627D0 (en) 1997-08-21 1997-08-21 Organic compositions
PCT/GB1998/002410 WO1999009962A1 (en) 1997-08-21 1998-08-10 In situ formation of polymeric material

Publications (1)

Publication Number Publication Date
BR9811245A true BR9811245A (pt) 2000-07-18

Family

ID=26312097

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811245-7A BR9811245A (pt) 1997-08-21 1998-08-10 Material polimérico farmaceuticamente aceitável, processo para a preparação de um material polimérico farmaceuticamente aceitável, uso de um polìmero aniÈnico ou tripolifosfato e de um polìmero catiÈnico, embalagem farmacêutica, e, formulação não aquosa para formar um material polimérico farmaceuticamente aceitável, in situ, em uma superfìcie do corpo

Country Status (16)

Country Link
US (1) US6391294B1 (pt)
EP (1) EP1007015B1 (pt)
JP (1) JP2001513549A (pt)
KR (1) KR20010023065A (pt)
CN (1) CN1267216A (pt)
AR (1) AR016850A1 (pt)
AT (1) ATE244562T1 (pt)
AU (1) AU737714B2 (pt)
BR (1) BR9811245A (pt)
CA (1) CA2301165C (pt)
DE (1) DE69816307T2 (pt)
ES (1) ES2198062T3 (pt)
GB (1) GB2328443B (pt)
HU (1) HUP0003602A2 (pt)
PL (1) PL192463B1 (pt)
WO (1) WO1999009962A1 (pt)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
AU5926800A (en) * 1999-07-08 2001-01-30 Nanocell, Inc. Semiconductor devices and process for manufacture
US8015677B2 (en) * 2000-12-01 2011-09-13 Aard-Balm Limited Embalming fluid
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
WO2003075886A1 (fr) * 2002-03-14 2003-09-18 Medrx Co., Ltd. Medicament topique pour soigner les plaies
US7666876B2 (en) 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
US7241453B2 (en) * 2002-04-05 2007-07-10 Long Island University Antimicrobial surfaces
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040057907A1 (en) * 2002-09-23 2004-03-25 Leonard Mackles Dri-nasal sprays
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
AU2003295577A1 (en) * 2002-11-14 2004-06-15 Zengen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
EP1784167A2 (en) * 2004-08-27 2007-05-16 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
JP5406529B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
EP1954770A4 (en) * 2005-11-29 2012-10-31 Ideal Cures Pvt Ltd AQUEOUS FILM COATING COMPOSITION WITH SODIUM ALGINATE AND ITS PRODUCTION
EP1810669A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Darreichungsform für Buprenorphin
CN101389309A (zh) * 2006-01-20 2009-03-18 莫诺索尔克斯有限公司 用于经粘膜给予活性组分的薄膜绷带
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
GB0707758D0 (en) * 2007-04-21 2007-05-30 Smith & Nephew A foam material for medical use and method for producing same
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
US8808259B2 (en) 2007-11-21 2014-08-19 T.J. Smith & Nephew Limited Suction device and dressing
EP3000448B2 (en) 2007-11-21 2022-03-09 Smith & Nephew PLC Wound dressing
US9149429B2 (en) * 2007-11-21 2015-10-06 The Procter & Gamble Company Preparations, methods and kits useful for the treatment of cough
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8298200B2 (en) 2009-06-01 2012-10-30 Tyco Healthcare Group Lp System for providing continual drainage in negative pressure wound therapy
CN102014885A (zh) 2008-04-21 2011-04-13 麦克内尔-Ppc股份有限公司 双喷雾罐式局部用药递送装置
MX2010012730A (es) * 2008-05-22 2011-03-01 Vesta Therapeutics Inc Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.
ES2731200T3 (es) 2009-12-22 2019-11-14 Smith & Nephew Inc Aparatos para terapia de herida por presión negativa
CA2786620C (en) * 2010-01-22 2020-01-14 Kci Licensing, Inc. Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
USRE48117E1 (en) 2010-05-07 2020-07-28 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
WO2012069794A1 (en) 2010-11-25 2012-05-31 Smith & Nephew Plc Composition i-ii and products and uses thereof
AU2011345328B2 (en) 2010-12-22 2016-03-10 Smith & Nephew, Inc. Apparatuses and methods for negative pressure wound therapy
EP2527053A1 (de) 2011-05-24 2012-11-28 Siemens Aktiengesellschaft Steuerverfahren für eine Walzstraße
DE102011077063A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem oder mehrerenaromatischen Alkoholen
CA2855347C (en) * 2011-11-13 2019-03-05 Suneris Inc. In-situ cross-linkable polymeric compositions and methods thereof
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
DE102011122236A1 (de) * 2011-12-09 2013-06-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung bei entzündlichen Erkrankungen der Haut und/oder Schleimhaut
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
TWI482632B (zh) * 2013-06-04 2015-05-01 Ming Jium Shieh 醫藥用載體及使用該載體的藥物結構
HRP20220112T1 (hr) 2013-12-24 2022-04-15 Virginia Commonwealth University Upotreba oksidacijskog sulfata kolesterola (ocs) za liječenje akutne insuficijencije jetre
EP2716282A1 (en) * 2014-01-09 2014-04-09 College of Pharmacy of Taif University Controlled release pharmaceutical composition
KR20160141607A (ko) 2015-06-01 2016-12-09 주식회사 성균관생활건강 커큐민이 코팅된 초콜릿 가공품 및 이의 제조방법
BR112017027625A2 (pt) 2015-06-22 2018-08-28 Cresilon, Inc. matriz polimérica adesiva hemostática altamente eficaz
EP3352738B1 (en) * 2015-09-24 2024-01-17 The Brigham and Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US10675365B2 (en) 2016-09-29 2020-06-09 Korea Atomic Energy Research Institute Curcumin derivative, method for producing same, and photo-acoustic imaging agent comprising same for detecting beta-amyloid plaque
TR201713929A2 (tr) * 2017-09-20 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
GB201811449D0 (en) 2018-07-12 2018-08-29 Smith & Nephew Apparatuses and methods for negative pressure wound therapy
GB202000574D0 (en) 2020-01-15 2020-02-26 Smith & Nephew Fluidic connectors for negative pressure wound therapy
CN118284424A (zh) * 2021-07-05 2024-07-02 雷鲁克斯美食有限责任公司 用于使用海藻酸盐、聚赖氨酸和种子防腐剂中和胃酸的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
JPS57106611A (en) * 1980-12-22 1982-07-02 Sanwa Kagaku Kenkyusho:Kk Coating remedy
US4501835A (en) 1982-03-08 1985-02-26 Polaroid Corporation Polyacrylic acid/chitosan polyelectrolyte complex
JPS5974984A (ja) * 1982-10-21 1984-04-27 Sumitomo Chem Co Ltd 固定化酵素もしくは固定化微生物の製造方法
EP0159604B1 (en) 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
US4996150A (en) * 1984-10-29 1991-02-26 Amoco Corporation Biocatalyst immobilization in a gel of anionic polysaccharide and cationic polymer
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4913743A (en) * 1987-04-15 1990-04-03 Biomatrix, Inc. Processes for managing keratinous material using glycosaminoglycan and cationic polymer combinations
DE3827561C1 (pt) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
AU9115791A (en) 1990-11-30 1992-06-25 Baker Cummins Dermatologicals, Inc. Skin protective compositions and method of inhibiting skin irritation
GB9026244D0 (en) * 1990-12-03 1991-01-16 Ghali Ragui L Granular liquid absorbents
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
AU636544B1 (en) * 1991-11-27 1993-04-29 Lignyte Co., Ltd. Water insoluble biocompatible hyaluronic acid polyion complex and method of making the same
DE69218555T2 (de) 1991-11-28 1997-08-21 Canon Kk Vorrichtung und Verfahren zur Herstellung eines Substrates für Informationsträger
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
FI95207C (fi) 1992-09-14 1996-01-10 Novasso Oy Haavansuojaside
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
JP4193917B2 (ja) * 1995-12-18 2008-12-10 アンジオデバイス インターナショナル ゲーエムベーハー 架橋ポリマー組成物およびその使用方法

Also Published As

Publication number Publication date
EP1007015A1 (en) 2000-06-14
HUP0003602A2 (en) 2001-03-28
PL338701A1 (en) 2000-11-20
PL192463B1 (pl) 2006-10-31
GB9817093D0 (en) 1998-10-07
ES2198062T3 (es) 2004-01-16
GB2328443B (en) 2001-09-05
AU737714B2 (en) 2001-08-30
EP1007015B1 (en) 2003-07-09
CN1267216A (zh) 2000-09-20
WO1999009962A1 (en) 1999-03-04
AU8738998A (en) 1999-03-16
CA2301165A1 (en) 1999-03-04
US6391294B1 (en) 2002-05-21
AR016850A1 (es) 2001-08-01
ATE244562T1 (de) 2003-07-15
JP2001513549A (ja) 2001-09-04
GB2328443A (en) 1999-02-24
DE69816307T2 (de) 2004-05-27
DE69816307D1 (de) 2003-08-14
CA2301165C (en) 2007-01-09
KR20010023065A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
BR9811245A (pt) Material polimérico farmaceuticamente aceitável, processo para a preparação de um material polimérico farmaceuticamente aceitável, uso de um polìmero aniÈnico ou tripolifosfato e de um polìmero catiÈnico, embalagem farmacêutica, e, formulação não aquosa para formar um material polimérico farmaceuticamente aceitável, in situ, em uma superfìcie do corpo
BR9916247A (pt) Composição de condicionamento, e, métodos para tratar um substrato à base de queratina e para tratar o cabelo
BR9303013A (pt) Composto,raloxifexo,cloridrato de raloxifeno e formulacao farmaceutica
BR9708427A (pt) Processo para incluir um enchimento particulado fino em papel de seda utilizando um polieletrólito aniônico
BR0101089A (pt) Máquina para aplicar tinta a superfìcies de estrada
ATE302614T1 (de) Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
DK0810856T3 (da) Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse
DE60033445D1 (de) Handschuh mit aloe vera und sein herstellungsverfahren
BR9202672A (pt) Processo e aparelho para depositar uma composicao cosmetica colorida sobre a pele ou outra parte do corpo,composicao eletrostaticamente pulverizavel,e,uso de pulverizacao eletrostatica
ATE243567T1 (de) Schnellbindende latexbeschichtungen und zubereitungen
NZ504216A (en) Use of unsubstituted polydiallylamines as bile sequestering agents to treat hypercholesterolemia
AR031957A1 (es) Un articulo absorbente con composiciones no acuosas conteniendo polimeros anionicos y un metodo para aplicar composiciones a un articulo absorbente
TWI251606B (en) Polymer nanocomposites and the process of preparing the same
BR9811333A (pt) Aplicação de substâncias em um pacote
BR9602922A (pt) Composição mistura estabilizadora uso e processo para a preparação de um polímero
PT90124A (pt) Processo para a preparacao de composicoes farmaceuticas de piroxicamo em solucoes aquosas
FR2709661B1 (fr) Dispositif pour tenir un outil auxiliaire de préférence en forme de plaque, servant à l'odontogenèse, notamment d'une calotte de base, dans un articulateur.
HUP9902165A2 (hu) Nagy fajlagos felületű D-mannit, eljárás előállítására, valamint ilyen mannitot tartalmazó szilárd kompozíciók
WO2000012623A3 (en) Use of 5-th receptor antagonists for the treatment of parkinson's disease
FR2705914B1 (fr) Dispositif d'application de pression, éventuellement chauffant, sur une surface de forme quelconque, notamment pour la réparation de structures endommagées.
BR0002139A (pt) Mistura para polimento de superfìcies, e, processo para polimento.
FR2750047B1 (fr) Composition cosmetique ou dermatologique sous forme d'un gel aqueux de forte viscosite
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9709907A (pt) Marcacão de formas de dosagem de rápida desintegracão
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]